Serum Thyroglobulin Measured With a Second-Generation Assay in Patients Undergoing Total Thyroidectomy Without Radioiodine Remnant Ablation: A Prospective Study

Thyroid : Official Journal of the American Thyroid Association
Pedro Weslley S do RosárioMaria Regina Calsolari

Abstract

Follow-up consisting of the measurement of nonstimulated serum thyroglobulin (Tg) combined with neck ultrasonography is recommended for patients with papillary thyroid carcinoma without indication for radioiodine ablation. There is no recommendation of thyrotropin suppression during this follow-up. New-generation Tg assays have been increasingly used, but few studies involve patients submitted only to thyroidectomy and they have several limitations. The objective of this prospective study was to define expected concentrations of nonstimulated Tg measured with a second-generation assay after total thyroidectomy in the absence of tumor. Serum Tg was measured using a second-generation assay in 69 patients without tumor and serum thyrotropin between 0.5 and 2 mIU/L, 3, 6, 12, and 24 months after total thyroidectomy. All patients had undetectable anti-Tg antibodies. Serum Tg was undetectable in 44.4%, 57%, 62.5%, and 62.1% of the patients 3, 6, 12, and 24 months after thyroidectomy, respectively, and was ≤0.5 ng/mL in 60.3%, 80%, 90.6%, and 90.9% of patients. All patients had a Tg≤2 ng/mL 6 months after thyroidectomy, and 97% had a Tg≤1 ng/mL 24 months after surgery. There was no case of Tg conversion from undetectable to detectable...Continue Reading

References

Jun 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M HocevarL Stanovnik
Jan 29, 1998·The New England Journal of Medicine·M J Schlumberger
Mar 11, 2003·Thyroid : Official Journal of the American Thyroid Association·Zubair BalochUNKNOWN Guidelines Committee, National Academy of Clinical Biochemistry
Sep 11, 2003·Annals of Internal Medicine·Luca ChiovatoAldo Pinchera
Mar 12, 2005·Arquivos brasileiros de endocrinologia e metabologia·Pedro Weslley S do RosárioSaulo Purisch
Jul 11, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Luca GiovanellaGiuseppe Spriano
Oct 29, 2009·Thyroid : Official Journal of the American Thyroid Association·UNKNOWN American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid CancerR Michael Tuttle
Jul 8, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·H Tala, R M Tuttle
Mar 11, 2011·The Journal of Clinical Endocrinology and Metabolism·M BrassardUNKNOWN THYRDIAG Working Group
Mar 27, 2012·The Medical Clinics of North America·Furio Pacini, Maria Grazia Castagna
Jun 6, 2012·Thyroid : Official Journal of the American Thyroid Association·Chisato Tomoda, Akira Miyauchi
May 15, 2013·Lancet·Donald S A McLeodDavid S Cooper
Jul 6, 2013·Arquivos brasileiros de endocrinologia e metabologia·Pedro Weslley RosárioUNKNOWN Sociedade Brasileira de Endocrinologia e Metabologia
Aug 8, 2013·The Journal of Clinical Endocrinology and Metabolism·Matthew D Ringel, Fadi Nabhan
Nov 29, 2013·The Journal of Clinical Endocrinology and Metabolism·Luca GiovanellaFrederik A Verburg
Apr 5, 2014·Thyroid : Official Journal of the American Thyroid Association·Trevor E AngellJonathan S LoPresti
Jun 18, 2014·BMJ : British Medical Journal·Juan P BritoJohn C Morris
Jul 6, 2014·Clinical Endocrinology·Petros PerrosUNKNOWN British Thyroid Association

❮ Previous
Next ❯

Citations

Oct 28, 2015·Endocrine-related Cancer·Gabriela Franco MourãoMaria Regina Calsolari
May 27, 2020·The Journal of Clinical Endocrinology and Metabolism·Antonio MatroneRossella Elisei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.